No headlines found.
No press releases found.
No news found.
Roundhill Uranium ETF is an actively managed and does not seek to track the performance of an index. The Fund seeks to provide investors with exposure to changes in the price of physical uranium, in the form of Triuranium Octoxide (U308). Uranium in this form is a uranium oxide commonly used as an intermediate product in the uranium production process. U308 serves as a precursor in the nuclear fuel cycle. It is converted into uranium hexafluoride (UF) during the enrichment process, which increases the concentration of the fissile isotope U-235. The enriched uranium is then fabricated into fuel rods for nuclear reactors. The Fund seeks to provide exposure to uranium through investments in swap agreements that utilize the spot price of uranium as the reference asset ("Spot Uranium Derivatives"). The spot price for uranium is determined through private negotiations between buyers and sellers since, unlike for other commodities, there is no formal exchange for uranium. The Fund will measure the spot price of uranium utilizing the daily settlement price of front month UxC Uranium U308 Futures published by CME Group, which are calculated based on the arithmetic average of all weekly spot U308 prices published in Ux Weekly during the contract month by UxC, LLC (UxC).
Roundhill Uranium ETF trades on the BATS stock market under the symbol UX.
As of January 22, 2026, UX stock price climbed to $34.60 with 6,258 million shares trading.
UX has a market cap of $3.11 million. This is considered a Sub-Micro Cap stock.
UX support price is $33.17 and resistance is $34.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UX shares will trade within this expected range on the day.
